Zeng Zifeng, Luo Rongtai, Xu Weiyong, Yao Huaqing, Lan Xinping
Center for Cardiovascular Diseases, Meizhou People's Hospital, Meizhou, People's Republic of China.
Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases, Meizhou People's Hospital, Meizhou, People's Republic of China.
Int J Gen Med. 2025 Jun 27;18:3501-3513. doi: 10.2147/IJGM.S523100. eCollection 2025.
The occurrence of cerebral infarction significantly increases the risk of major adverse cardiovascular events in patients with acute myocardial infarction (AMI), highlighting the importance of early identification and intervention. Currently, no validated tools exist for individualized risk stratification of cerebral infarction (CI) in patients with AMI.
This study aimed to identify the most valuable predictors (MVPs) of in-hospital first-onset CI in AMI patients and construct a nomogram for risk stratification.
This retrospective cohort study enrolled 1,350 AMI patients admitted to the Cardiovascular Center of Meizhou People's Hospital between January and December 2022. Clinical characteristics and laboratory parameters were analyzed. Least Absolute Shrinkage and Selection Operator regression (LASSO) was used to select MVPs. The nomogram was developed by integrating coefficients of MVPs from logistic regression, and its discrimination, calibration, and clinical utility were validated in the cohort. The optimal cutoff value of the nomogram probability was determined.
CI occurred in 60 patients (4.44%). MVPs included Killip classification ( = 1.42, 1.05-1.93), PCI therapy ( = 0.29, 0.16-0.51), C-reactive protein (CRP: = 1.01, 1.00-1.01), blood urea nitrogen (BUN: = 1.03, 0.99-1.07), and neutrophil-to-lymphocyte ratio (NLR: = 1.02, 0.99-1.05). The discriminatory ability of the nomogram was up to 0.804( 0.749-0.859). Additionally, the nomogram showed good calibration and clinical utility in the cohort. Furthermore, the optimal cutoff value of the nomogram probability for distinguishing those who will experience in-hospital first-onset CI was 0.035 (sensitivity 78.3%, specificity 71.1%).
The first nomogram integrating multimodal predictors for discerning AMI patients who will experience in-hospital first-onset CI was developed and validated, which will aid clinicians in clinical decision-making.
脑梗死的发生显著增加了急性心肌梗死(AMI)患者发生主要不良心血管事件的风险,凸显了早期识别和干预的重要性。目前,尚无经过验证的工具可用于对AMI患者的脑梗死(CI)进行个体化风险分层。
本研究旨在确定AMI患者院内首次发生CI的最有价值预测因素(MVPs),并构建风险分层列线图。
这项回顾性队列研究纳入了2022年1月至12月期间在梅州市人民医院心血管中心住院的1350例AMI患者。分析了临床特征和实验室参数。采用最小绝对收缩和选择算子回归(LASSO)来选择MVPs。通过整合逻辑回归中MVPs的系数来构建列线图,并在队列中验证其区分能力、校准能力和临床实用性。确定列线图概率的最佳截断值。
60例患者(4.44%)发生了CI。MVPs包括Killip分级(β = 1.42,95%CI 1.05 - 1.93)、PCI治疗(β = 0.29,95%CI 0.16 - 0.51)、C反应蛋白(CRP:β = 1.01,95%CI 1.00 - 1.01)、血尿素氮(BUN:β = 1.03,95%CI 0.99 - 1.07)和中性粒细胞与淋巴细胞比值(NLR:β = 1.02,95%CI 0.99 - 1.05)。列线图的区分能力高达0.804(95%CI 0.749 - 0.859)。此外,列线图在队列中显示出良好的校准能力和临床实用性。此外,用于区分将发生院内首次CI的患者的列线图概率的最佳截断值为0.035(敏感性78.3%,特异性71.1%)。
开发并验证了首个整合多模式预测因素以识别将发生院内首次CI的AMI患者的列线图,这将有助于临床医生进行临床决策。